WEBULL

Analyst Estimates: Here's What Brokers Think Of Mapletree Pan Asia Commercial Trust (SGX:N2IU) After Its Third-Quarter Report

Simply Wall St · 02/01 00:15

Last week saw the newest third-quarter earnings release from Mapletree Pan Asia Commercial Trust (SGX:N2IU), an important milestone in the company's journey to build a stronger business. Results were roughly in line with estimates, with revenues of S$219m and statutory earnings per share of S$0.11. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

earnings-and-revenue-growth
SGX:N2IU Earnings and Revenue Growth February 1st 2026

Following last week's earnings report, Mapletree Pan Asia Commercial Trust's 13 analysts are forecasting 2027 revenues to be S$881.3m, approximately in line with the last 12 months. Statutory earnings per share are expected to tumble 40% to S$0.078 in the same period. In the lead-up to this report, the analysts had been modelling revenues of S$882.6m and earnings per share (EPS) of S$0.078 in 2027. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

See our latest analysis for Mapletree Pan Asia Commercial Trust

It will come as no surprise then, to learn that the consensus price target is largely unchanged at S$1.57. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Mapletree Pan Asia Commercial Trust analyst has a price target of S$1.84 per share, while the most pessimistic values it at S$1.35. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that revenue is expected to reverse, with a forecast 0.9% annualised decline to the end of 2027. That is a notable change from historical growth of 15% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 2.5% per year. It's pretty clear that Mapletree Pan Asia Commercial Trust's revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Mapletree Pan Asia Commercial Trust's revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Mapletree Pan Asia Commercial Trust going out to 2028, and you can see them free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Mapletree Pan Asia Commercial Trust (at least 2 which don't sit too well with us) , and understanding them should be part of your investment process.